How did LivaNova PLC (LIVN) surprise investors with its report?

LivaNova PLC [LIVN] stock prices are up 0.19% to $53.72 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The LIVN shares have gain 4.62% over the last week, with a monthly amount glided 13.07%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


On 17, November 2022, LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System. In a post published today on Yahoo Finance, Platform simplifies life support, making life-saving technology more accessible to hospitals and critically ill patients.

From an analyst’s perspective:

LivaNova PLC [NASDAQ: LIVN] stock has seen the most recent analyst activity on April 06, 2022, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $95. Previously, UBS upgraded its rating to Buy on February 24, 2022, and kept the price target unchanged to $96. On December 03, 2021, Goldman initiated with a Buy rating and assigned a price target of $108 on the stock. Needham reiterated its Buy rating and increased its price target to $117 on August 20, 2021. Needham upgraded its rating to a Buy but $93 remained the price target by the analyst firm on July 20, 2021. Berenberg downgraded its rating to Hold for this stock on March 03, 2021, but kept the price target unchanged to $84. In a note dated January 05, 2021, Needham downgraded an Hold rating on this stock.

The stock price of LivaNova PLC [LIVN] has been fluctuating between $41.82 and $89.69 over the past year. Currently, Wall Street analysts expect the stock to reach $72.33 within the next 12 months. LivaNova PLC [NASDAQ: LIVN] shares were valued at $53.72 at the most recent close of the market. An investor can expect a potential return of 34.64% based on the average LIVN price forecast.

Analyzing the LIVN fundamentals

The most recent quarter, LivaNova PLC [NASDAQ:LIVN] reported sales of 252.6 billion, representing a drop of -0.20%. Gross Margin for this corporation currently stands at +68.24% with Operating Margin at +6.15%, Pretax Margin comes in at -12.02%, and Net Margin reading is -13.12%.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 52.81 points at the first support level, and at 51.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 54.67, and for the 2nd resistance point, it is at 55.62.

LivaNova PLC [LIVN] reported earnings per share of $0.53 for its fiscal quarter that ended on 6/29/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.52/share, meaning a difference of $0.01 and a surprise factor of 1.90%. By comparison, the stated earnings for the previous quarter ended on 3/30/2022 were $0.48 per share as compared to estimates of $0.48 per share, a difference of $0 representing a surprise of 0.00%.

Ratios To Look Out For

It’s worth pointing out that LivaNova PLC [NASDAQ:LIVN]’s Current Ratio is 3.00. Further, the Quick Ratio stands at 0.82, while the Cash Ratio is 0.30. Considering the valuation of this stock, the price to sales ratio is 4.28, the price to book ratio is 3.60.

Transactions by insiders

Insider trading, which has resulted in 2 insider purchases of 740 shares and 2 insider sales of 348 shares in the past three months, is now the topic of our analysis. Recent insider trading involved Moore Daniel Jeffrey, Director, that happened on Apr 01 when 1000.0 shares were sold. CEO, McDonald Damien completed a deal on Mar 29 to sell 2784.0 shares. Meanwhile, Director Moore Daniel Jeffrey sold 1000.0 shares on Mar 02.